Literature DB >> 20825757

Is classical transurethral resection of the prostate, the gold standard endoscopic treatment for benign prostate hyperplasia, in real danger of being replaced?

Petrisor Geavlete.   

Abstract

Entities:  

Mesh:

Year:  2010        PMID: 20825757     DOI: 10.1016/j.eururo.2010.06.001

Source DB:  PubMed          Journal:  Eur Urol        ISSN: 0302-2838            Impact factor:   20.096


× No keyword cloud information.
  5 in total

1.  Laser ablation of the prostate: a safe effective treatment of obstructive benign prostatic disease.

Authors:  Edward Woods
Journal:  Can Urol Assoc J       Date:  2010-10       Impact factor: 1.862

Review 2.  Follow-up of Temporary Implantable Nitinol Device (TIND) Implantation for the Treatment of BPH: a Systematic Review.

Authors:  Riccardo Bertolo; Cristian Fiori; Daniele Amparore; Francesco Porpiglia
Journal:  Curr Urol Rep       Date:  2018-04-26       Impact factor: 3.092

3.  Photoselective vaporization of the prostate using GreenLight 120-W lithium triborate laser to treat symptomatic benign prostatic hyperplasia: A single-centre prospective study.

Authors:  Hisham A Mosli; Taha A Abdel-Meguid; Mohammad H Abdulwahhab; Ahmad Al-Sayyad; Hasan M Farsi; Abdulmalik Tayib
Journal:  Can Urol Assoc J       Date:  2013-04-16       Impact factor: 1.862

Review 4.  An Update on the Outcomes of Patients Treated with Urolift for Benign Prostatic Hyperplasia.

Authors:  Justin Loloi; Nathan Feiertag; Kripali Gautam; Pedro Maria
Journal:  Res Rep Urol       Date:  2021-06-11

5.  Bipolar transurethral enucleation and resection of the prostate versus bipolar resection of the prostate for prostates larger than 60gr: A retrospective study at a single academic tertiary care center.

Authors:  Yong Wei; Ning Xu; Shao-Hao Chen; Xiao-Dong Li; Qing-Shui Zheng; Yun-Zhi Lin; Xue-Yi Xue
Journal:  Int Braz J Urol       Date:  2016 Jul-Aug       Impact factor: 1.541

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.